Salva Francisco D. — SEC Form 4 filings

SEC reporting owner CIK 1834051. 6 Form 4 filings on record with FilingPulse; latest filed 2026-06-18.

Transaction summary — filings shown

Covers all 6 filings on record, filed 2024-02-15 to 2026-06-18. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Azitra, Inc. (AZTR)President and CEO, Director51 leg · 333,300 sh · $99,9907
Vincerx Pharma, Inc. (VINC)Director11

Form 4 filings — Salva Francisco D.

FiledFormIssuerReported transactionsSource
2026-06-184Azitra, Inc. (AZTR)Conversion (C): 4,064,050 · Conversion (C): 500 (derivative)EDGAR
2026-04-224Azitra, Inc. (AZTR)Grant/award (A): 220,879 (derivative) @ $0EDGAR
2026-03-204Azitra, Inc. (AZTR)Purchase (P): 500 (derivative) · Purchase (P): 4,064,050 (derivative) · Purchase (P): 4,064,050 (derivative)EDGAR
2025-12-224Azitra, Inc. (AZTR)Grant/award (A): 59,309 (derivative) @ $0EDGAR
2024-05-284Vincerx Pharma, Inc. (VINC)Grant/award (A): 15,000 (derivative) @ $0EDGAR
2024-02-154Azitra, Inc. (AZTR)Purchase (P): 333,300 @ $0.30EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1834051 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →